Circular RNA circ_0026218 Suppressed Atherosclerosis Progression via miR-338-3p/SIRT6 Axis

Liang Yang1, Wei Chen1, Bin Li1

  • 1Heart Center, Guilin People's Hospital, Guilin, 541002 Guangxi, China.

Insights

Circular RNA 0026218 (circ_0026218) protects against atherosclerosis by upregulating SIRT6 via sponging microRNA-338-3p. This mechanism inhibits oxidized low-density lipoprotein-induced injury in human umbilical vein endothelial cells, highlighting circ_0026218

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) play a role in atherosclerosis (AS) pathogenesis.
  • The specific function of circRNA 0026218 (circ_0026218) in AS is not well understood.
  • Investigating circ_0026218's role in vascular endothelial cell injury is crucial for understanding AS.

Purpose of the Study:

  • To elucidate the function and mechanism of circ_0026218 in AS.
  • To determine the effect of circ_0026218 on oxidized low-density lipoprotein (ox-LDL)-induced injury in human umbilical vein endothelial cells (HUVECs).
  • To explore the relationship between circ_0026218, microRNA-338-3p (miR-338-3p), and silent information regulator 6 (SIRT6).

Main Methods:

  • Differential expression screening of circRNAs in AS using microarray analysis.
  • Establishment of an ox-LDL-induced HUVEC injury model.
  • Assessment of cell viability, inflammatory response, oxidative stress, and apoptosis.
  • Investigation of molecular interactions using dual-luciferase reporter and RNA immunoprecipitation (RIP) assays.
  • Validation of protein expression changes via Western blot.

Main Results:

  • circ_0026218 expression was significantly decreased in ox-LDL-treated HUVECs.
  • Overexpression of circ_0026218 enhanced HUVEC viability and attenuated inflammatory response, oxidative stress, and apoptosis.
  • circ_0026218 directly targets miR-338-3p, acting as a molecular sponge.
  • circ_0026218 positively regulates SIRT6 expression by inhibiting miR-338-3p.
  • Inhibition of miR-338-3p reversed the protective effects of circ_0026218.

Conclusions:

  • circ_0026218 protects HUVECs from ox-LDL-induced injury by upregulating SIRT6 expression through sponging miR-338-3p.
  • circ_0026218 is implicated in the pathogenesis of atherosclerosis.
  • circ_0026218 represents a potential therapeutic target for AS.
Abstract

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K